Aleje Jerozolimskie 65/79, 00-697 Warsaw, Poland

Global Point-of-Care Testing (POCT) Market 2024 Industry Trends, Market Size, Segments, Growth Prospects, by Key Players Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic


Global Point-of-Care Testing (POCT) Market 2024 Industry Trends, Market Size, Segments, Growth Prospects, by Key Players Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic

Global Point-of-Care Testing (POCT) MarketPress Release

Global Point-of-Care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits), Prescription Mode (Prescription & OTC), Distribution Channel, End User, Geography- Trends and Forecast to 2024

 Global Point-of-Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request Sample Copy Of this Report @

Market Key Drivers: Global Point of Care Testing (POCT)

Some major factors driving the market for Point-Of-Care Testing market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place, and enhanced patient compliance are also driving the growth for the point-of-care testing market.

  • High cost, stringent regulatory framework, product recalls and reluctance from the industry towards changing the existing norms are some of the factors which may hinder the growth of the market.
  • As increased awareness among the population driving the growth for the point-of-care testing market.
  • POCT has become significant part of patient care at various health care facilities.
  • Ease of use and rapid test will drive the market in future.

  Points to focus in the report

  1. The report offers market share appraisals for regional and global levels
  2. To gain detailed overview of parent market
  3. Information about key drivers, restraints, opportunities, and their impact analysis on the market size has been provided.
  4. The study provides an in-depth analysis of the market & current & future trends to elucidate imminent investment pockets.

For More Information On This Report, Please Visit @

Major Topics Covered in this Report:

  1.  Study Coverage
  2.  Executive Summary
  3. Market Size by Manufacturers
  4. Market Size by Type
  5. Market Size by Application
  6. Manufacturers Profiles
  7.  Production Forecasts
  8.  Consumption Forecast
  9. Upstream, Industry Chain and Downstream Customers Analysis
  10.  Opportunities & Challenges, Threat and Affecting Factors
  11.  Key Findings
  12.  Appendix 

For Report TOC Request Here:

Report Scope

Market drivers and restrains

Key trends of the market

Challenges of market growth

Major players in the market

CAGR values for the forecast period and historic years

Key Features of the Report

Key developments and product launches by the top players and brands

Key parameters which are driving the market

Key trends of the market

Challenges of market growth

What are the challenges being faced by the new entrants

Market volume

Top Key Players Covered In This Report:

The global point-of-care market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. F. Hoffmann-La Roche Ltd dominated the point-of-care market accounting for a highest market share in 2016, followed by Siemens AG and Abbott. Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedicaamong others holds 53.1% of the global injectable drug delivery market in 2016.


Historical Background – Roche was established in 1896

Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.

Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.

Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

  1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
  2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
  3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.


Historical Background: Siemens AG was established in 1847

Nature of business: Siemens AG is a German leading company specializing in supplier of systems for power generation and transmission, medical diagnosis, infrastructure and industry solutions.

Main focus: Since the establishment in 1847, the company’s main focus is on electrification, automation and digitalization

Main Business areas: power and gas, wind power and renewable, energy management, building technologies, mobility, digital factory and process industries.

Subsidiary: Siemens Healthcare operates in more than 200 countries across United States, Europe, Western Hemisphere, Africa, and Asia-Pacific SA/NV, Beersel (Belgium), ETM professional control GmbH, Eisenstadt (Austria), Siemens Healthcare Diagnostics Products GmbH (Marburg), Linacre Investments (Pty) Ltd., Kenilworth (South Africa), Siemens Healthcare FZ LLC (Dubai).

Recent Developments:

  1. In November 2016, Siemens strengthened its healthcare business through public listing to give more focus and flexibility in pursuing its growth strategy.
  2. In June 2016, Siemens opened a new headquarter in Munich to enhance its global presence in this market.


Historical Background: Abbott was established in 1888.

Nature of business: Abbott is a globally diversified healthcare company focused on development and marketing of diagnostics products, medical devices, nutrition and branded generic pharmaceuticals.

Main focus: Since the establishment in 1888, the company’s main focus is on established pharmaceutical, molecular diagnostics, diabetes care and nutritionals.

Main Business areas: Established pharmaceuticals, molecular diagnostics, diabetes care nutritionals, and vascular.

Subsidiary:Abbott operates in more than 150 countries across United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. For instance, Abbott Administration Inc. (Delaware), Abbott Home Infusion Services, Inc. (New York), Abbott Laboratories International Co. (Illinois), Abbott Australasia Pty Ltd.(Australia), Murex Diagnostics International, Inc. (Barbados), Abbott S.A. (Belgium).

Recent Developments:

  1. In May 2017, Abbott announced CE Mark approval and its use of the new Rx Insertable Cardiac Monitor (ICM), which is the world’s first smartphone compatible ICM to identify or detect cardiac arrhythmias, including atrial fibrillation (AF), for therapy.
  2. In May 2017, Abbott announced the national reimbursement for freestyle Libre in France, providing access to revolutionary technology for people suffering with diabetes. This would help thousands of people to have access to test type 1 and type 2 diabetes.
  3. In February 2017, FDA granted the use of Abbott Real Time Zika test product to detect Zika virus in whole blood samples for use of in vitro diagnostic tests during emergencies.

To Enquire Regarding This Report @

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at [email protected]

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]



Tags: , , , ,